Literature DB >> 26720903

Basic calcium phosphate crystals and osteoarthritis pathogenesis: novel pathways and potential targets.

John Stack1, Geraldine McCarthy.   

Abstract

PURPOSE OF REVIEW: Basic calcium phosphate (BCP) crystals have long been associated with the pathogenesis of osteoarthritis. As our knowledge concerning BCP crystals in osteoarthritis expands, so does the potential to develop targeted therapies. The present review discusses recent advances in this field and attempts to summarize our current understanding regarding the role of BCP crystals in osteoarthritis pathogenesis. RECENT
FINDINGS: BCP crystals injected into the knees of mice induce osteoarthritis-like changes, further evidence of their pathogenic properties. Interleukin-6 has emerged as a key cytokine involved in BCP crystal-induced inflammation that could represent a potential therapeutic target. The role of BCP crystal-induced osteoclastogenesis has also recently been explored and may also hold the key to future targeted therapies. Although tools to detect BCP crystals remain limited, dual energy computerized tomography scanning has emerged as a useful noninvasive means of quantifying intra-articular calcium crystal deposition.
SUMMARY: BCP crystals can activate a number of inflammatory pathways which in turn may lead to cartilage degradation and osteoarthritis. Understanding of these pathways may ultimately yield targeted therapies for osteoarthritis, for which none currently exists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26720903     DOI: 10.1097/BOR.0000000000000245

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  9 in total

1.  Crystal arthritis: Crystallizing our ideas about gout and osteoarthritis.

Authors:  Geraldine M McCarthy; Laura Durcan
Journal:  Nat Rev Rheumatol       Date:  2017-10-12       Impact factor: 20.543

Review 2.  Therapeutic options for targeting inflammatory osteoarthritis pain.

Authors:  Philip G Conaghan; Andrew D Cook; John A Hamilton; Paul P Tak
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

3.  Calcium-phosphate complex increased during subchondral bone remodeling affects earlystage osteoarthritis.

Authors:  Youn-Kwan Jung; Min-Su Han; Hye-Ri Park; Eun-Ju Lee; Ji-Ae Jang; Gun-Woo Kim; Sun-Young Lee; DaeWon Moon; Seungwoo Han
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

4.  Interleukin‑Iβ promotes cartilage degeneration by regulating forkhead box protein O4 and type Ⅱ collagen.

Authors:  Jianxiong Wu; Hongjun Zhang; Rulin Deng; Lifeng Xing; Mingwu Hu; Xiaoling Fu
Journal:  Mol Med Rep       Date:  2021-09-22       Impact factor: 2.952

Review 5.  Mitochondria in Injury, Inflammation and Disease of Articular Skeletal Joints.

Authors:  James Orman Early; Lauren E Fagan; Annie M Curtis; Oran D Kennedy
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

6.  Chondrocyte-derived exosomes promote cartilage calcification in temporomandibular joint osteoarthritis.

Authors:  Qian Liu; Ruoxin Wang; Shujie Hou; Feng He; Yuanjun Ma; Tao Ye; Shibin Yu; Hongwei Chen; Helin Wang; Mian Zhang
Journal:  Arthritis Res Ther       Date:  2022-02-14       Impact factor: 5.156

Review 7.  Disease-Associated Particulates and Joint Inflammation; Mechanistic Insights and Potential Therapeutic Targets.

Authors:  Olwyn R Mahon; Aisling Dunne
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

8.  Calcium-Phosphate Crystals Promote RANKL Expression via the Downregulation of DUSP1.

Authors:  YunJeong Choi; Ji Hyun Yoo; Youngkyun Lee; Moon Kyoung Bae; Hyung Joon Kim
Journal:  Mol Cells       Date:  2019-01-24       Impact factor: 5.034

9.  The protective role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H2S) pathway against experimental osteoarthritis.

Authors:  Sonia Nasi; Driss Ehirchiou; Athanasia Chatzianastasiou; Noriyuki Nagahara; Andreas Papapetropoulos; Jessica Bertrand; Giuseppe Cirino; Alexander So; Nathalie Busso
Journal:  Arthritis Res Ther       Date:  2020-03-17       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.